Bilal Abuasal

510 total citations
16 papers, 420 citations indexed

About

Bilal Abuasal is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Immunology. According to data from OpenAlex, Bilal Abuasal has authored 16 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Bilal Abuasal's work include Pharmaceutical studies and practices (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Genomics and Rare Diseases (3 papers). Bilal Abuasal is often cited by papers focused on Pharmaceutical studies and practices (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Genomics and Rare Diseases (3 papers). Bilal Abuasal collaborates with scholars based in United States, Saudi Arabia and Canada. Bilal Abuasal's co-authors include Amal Kaddoumi, Paul W. Sylvester, Hisham Qosa, Babette B. Weksler, Ignacio A. Romero, Jeffrey N. Keller, Mohamed R. Akl, Michael B. Bolger, Don K. Walker and Sami Nazzal and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Neuropharmacology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Bilal Abuasal

15 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bilal Abuasal United States 10 114 94 80 68 62 16 420
Cheng-Ying Hsieh Taiwan 15 260 2.3× 47 0.5× 54 0.7× 61 0.9× 33 0.5× 23 728
Syed Anees Ahmed India 16 188 1.6× 96 1.0× 33 0.4× 44 0.6× 26 0.4× 35 591
P.-D.L. Chao Taiwan 11 167 1.5× 55 0.6× 49 0.6× 99 1.5× 30 0.5× 31 484
Alaa H. Abuznait United States 10 178 1.6× 232 2.5× 55 0.7× 288 4.2× 84 1.4× 11 734
Rataya Luechapudiporn Thailand 8 194 1.7× 115 1.2× 68 0.8× 22 0.3× 37 0.6× 19 623
Haojing Rong United States 15 300 2.6× 89 0.9× 50 0.6× 128 1.9× 23 0.4× 31 695
Yakup Berkay Yılmaz Türkiye 8 170 1.5× 55 0.6× 36 0.5× 20 0.3× 29 0.5× 11 549
Phikelelani Ngubane South Africa 14 179 1.6× 100 1.1× 20 0.3× 52 0.8× 43 0.7× 62 558
Tarique Anwer Saudi Arabia 18 191 1.7× 37 0.4× 38 0.5× 99 1.5× 47 0.8× 45 839
Judit Müller Hungary 12 118 1.0× 31 0.3× 25 0.3× 40 0.6× 16 0.3× 19 365

Countries citing papers authored by Bilal Abuasal

Since Specialization
Citations

This map shows the geographic impact of Bilal Abuasal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilal Abuasal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilal Abuasal more than expected).

Fields of papers citing papers by Bilal Abuasal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilal Abuasal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilal Abuasal. The network helps show where Bilal Abuasal may publish in the future.

Co-authorship network of co-authors of Bilal Abuasal

This figure shows the co-authorship network connecting the top 25 collaborators of Bilal Abuasal. A scholar is included among the top collaborators of Bilal Abuasal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilal Abuasal. Bilal Abuasal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Abuasal, Bilal, et al.. (2025). Unlocking the Mysteries of Rare Disease Drug Development: A Beginner's Guide for Clinical Pharmacologists. Clinical and Translational Science. 18(4). e70215–e70215. 1 indexed citations
2.
Wang, Yow‐Ming, Ólanrewaju O. Okusanya, Bilal Abuasal, et al.. (2024). Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins. Clinical Pharmacology & Therapeutics. 115(3). 440–451. 6 indexed citations
3.
Krishna, Rajesh, Amitava Mitra, Yuen Yi Hon, et al.. (2024). Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers. Clinical Pharmacology & Therapeutics. 116(6). 1412–1432. 6 indexed citations
4.
Burton, Jackson, Bilal Abuasal, Jamie N. Connarn, et al.. (2023). Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision. Clinical Pharmacology & Therapeutics. 114(3). 507–510.
5.
Izmailova, Elena S., et al.. (2023). Digital technologies: Innovations that transform the face of drug development. Clinical and Translational Science. 16(8). 1323–1330. 9 indexed citations
6.
Dwivedi, Gaurav, et al.. (2023). Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases. Journal of Pharmacokinetics and Pharmacodynamics. 50(6). 429–444. 7 indexed citations
7.
Abuasal, Bilal, et al.. (2021). Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities. Clinical Pharmacology & Therapeutics. 111(4). 786–798. 11 indexed citations
8.
Abuasal, Bilal, et al.. (2020). Application of Clinical Pharmacology Principles in Drug Development of Modified‐Release Products: Leveraging Exposure‐Response Information to Support Approval. The Journal of Clinical Pharmacology. 60(11). 1441–1452. 2 indexed citations
9.
Qosa, Hisham, Bilal Abuasal, Ignacio A. Romero, et al.. (2014). Differences in amyloid-β clearance across mouse and human blood–brain barrier models: Kinetic analysis and mechanistic modeling. Neuropharmacology. 79. 668–678. 117 indexed citations
10.
Akl, Mohamed R., Nehad M. Ayoub, Bilal Abuasal, Amal Kaddoumi, & Paul W. Sylvester. (2012). Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines. Fitoterapia. 84. 347–359. 41 indexed citations
11.
Abuasal, Bilal, Hisham Qosa, Paul W. Sylvester, & Amal Kaddoumi. (2012). Comparison of the intestinal absorption and bioavailability of γ‐tocotrienol and α‐tocopherol: in vitro, in situ and in vivo studies. Biopharmaceutics & Drug Disposition. 33(5). 246–256. 37 indexed citations
12.
13.
Abuasal, Bilal, Michael B. Bolger, Don K. Walker, & Amal Kaddoumi. (2012). In SilicoModeling for the Nonlinear Absorption Kinetics of UK-343,664: A P-gp and CYP3A4 Substrate. Molecular Pharmaceutics. 9(3). 492–504. 39 indexed citations
14.
Abuasal, Bilal, Paul W. Sylvester, & Amal Kaddoumi. (2010). Intestinal Absorption of γ-Tocotrienol Is Mediated by Niemann-Pick C1-Like 1: In Situ Rat Intestinal Perfusion Studies. Drug Metabolism and Disposition. 38(6). 939–945. 48 indexed citations
15.
Behery, Fathy A., Ahmed Y. Elnagar, Mohamed R. Akl, et al.. (2010). Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors. Bioorganic & Medicinal Chemistry. 18(22). 8066–8075. 21 indexed citations
16.
Abuasal, Bilal, Shawn Thomas, Paul W. Sylvester, & Amal Kaddoumi. (2010). Development and validation of a reversed‐phase HPLC method for the determination of γ‐tocotrienol in rat and human plasma. Biomedical Chromatography. 25(5). 621–627. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cheng-Ying Hsieh Breakdown of academic impact, for papers by Syed Anees Ahmed Breakdown of academic impact, for papers by P.-D.L. Chao Breakdown of academic impact, for papers by Alaa H. Abuznait Breakdown of academic impact, for papers by Rataya Luechapudiporn Breakdown of academic impact, for papers by Haojing Rong Breakdown of academic impact, for papers by Yakup Berkay Yılmaz Breakdown of academic impact, for papers by Phikelelani Ngubane Breakdown of academic impact, for papers by Tarique Anwer Breakdown of academic impact, for papers by Judit Müller
Rankless by CCL
2026